Electrospinning completes £4.5m fundraising round

DSC01564 EditElectrospinning, a UK-based developer and manufacturer of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m (US$6.3m) fundraising round, led by US materials science company Confluent Medical Technologies as a strategic investor.

The proceeds of the fundraising round will be used to enhance the company’s capability and capacity through semi-automation, enhanced materials processing and quality systems.

For the full story, see the June 2021 edition of Medical Textiles.